QR Kodea

Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives

The expression of estrogen receptors (ERs) in breast cancer (BC) represents a strong prognostic and predictive biomarker and directs therapeutic decisions in early and advanced stages. ER-low-positive BC, defined by the immunohistochemical (IHC) expression of ERs from 1% to 9%, constitutes a distinc...

Deskribapen osoa

Gorde:
Egile Nagusiak: Christina Panagiotis Malainou, Nikolina Stachika, Aikaterini Konstantina Damianou, Aristotelis Anastopoulos, Ioanna Ploumaki, Efthymios Triantafyllou, Konstantinos Drougkas, Georgia Gomatou, Elias Kotteas
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2023-11-01
Saila:Current Oncology
Gaiak:
estrogen receptor
breast cancer
estrogen receptor-low-positive breast cancer
endocrine therapy
triple-negative breast cancer
Sarrera elektronikoa:https://www.mdpi.com/1718-7729/30/11/706
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak